Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East
- PMID: 36072822
- PMCID: PMC9398873
- DOI: 10.1155/2022/9617319
Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East
Abstract
This study aimed to assess the risk factors for COVID-19 mortality among hospitalized patients in Jordan. All COVID-19 patients admitted to a tertiary hospital in Jordan from September 20, 2020, to August 8, 2021, were included in this study. Demographics, clinical characteristics, comorbidities, and laboratory results were extracted from the patients' electronic records. Multivariable logistic and machine learning (ML) methods were used to study variable importance. Out of 1,613 COVID-19 patients, 1,004 (62.2%) were discharged from the hospital (survived), while 609 (37.8%) died. Patients who were of elderly age (>65 years) (OR, 2.01; 95% CI, 1.28-3.16), current smokers (OR, 1.61; 95%CI, 1.17-2.23), and had severe or critical illness at admission ((OR, 1.56; 95%CI, 1.05-2.32) (OR, 2.94; 95%CI, 2.02-4.27); respectively), were at higher risk of mortality. Comorbidities including chronic kidney disease (OR, 2.90; 95% CI, 1.90-4.43), deep venous thrombosis (OR, 2.62; 95% CI, 1.08-6.35), malignancy (OR, 2.22; 95% CI, 1.46-3.38), diabetes (OR, 1.31; 95% CI, 1.04-1.65), and heart failure (OR, 1.51; 95% CI, 1.02-2.23) were significantly associated with increased risk of mortality. Laboratory abnormalities associated with mortality included hypernatremia (OR, 11.37; 95% CI, 4.33-29.81), elevated aspartate aminotransferase (OR, 1.81; 95% CI, 1.42-2.31), hypoalbuminemia (OR, 1.75; 95% CI, 1.37-2.25), and low platelets level (OR, 1.43; 95% CI, 1.05-1.95). Several demographic, clinical, and laboratory risk factors for COVID-19 mortality were identified. This study is the first to examine the risk factors associated with mortality using ML methods in the Middle East. This will contribute to a better understanding of the impact of the disease and improve the outcome of the pandemic worldwide.
Copyright © 2022 Reema A. Karasneh et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this article.
Figures



Similar articles
-
Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.Allergy. 2021 Feb;76(2):533-550. doi: 10.1111/all.14496. Epub 2020 Aug 24. Allergy. 2021. PMID: 32662525 Free PMC article.
-
Clinical Features and Risk Factors for In-Hospital Mortality From COVID-19 Infection at a Tertiary Care Medical Center, at the Onset of the US COVID-19 Pandemic.J Intensive Care Med. 2021 Jun;36(6):711-718. doi: 10.1177/08850666211001799. Epub 2021 Mar 24. J Intensive Care Med. 2021. PMID: 33759606 Free PMC article.
-
Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.Eur Rev Med Pharmacol Sci. 2023 Sep;27(18):8962-8974. doi: 10.26355/eurrev_202309_33817. Eur Rev Med Pharmacol Sci. 2023. PMID: 37782206
-
Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.Front Immunol. 2023 Feb 28;14:1123497. doi: 10.3389/fimmu.2023.1123497. eCollection 2023. Front Immunol. 2023. PMID: 36926338 Free PMC article.
-
Comorbidities associated with risk of ICU admission in elderly patients with COVID-19: Data from academic hospital in Saudi Arabia.Medicine (Baltimore). 2022 Sep 30;101(39):e30799. doi: 10.1097/MD.0000000000030799. Medicine (Baltimore). 2022. PMID: 36181092 Free PMC article.
Cited by
-
Individual and mutual effects of diabetes, hypertension, and obesity on acute respiratory distress syndrome mortality rates in clinical patients: a multicentre study.Front Public Health. 2023 Jun 21;11:1219271. doi: 10.3389/fpubh.2023.1219271. eCollection 2023. Front Public Health. 2023. PMID: 37415703 Free PMC article.
-
Acid-base imbalance as a risk factor for mortality among COVID-19 hospitalized patients.Biosci Rep. 2023 Mar 29;43(3):BSR20222362. doi: 10.1042/BSR20222362. Biosci Rep. 2023. PMID: 36876487 Free PMC article.
-
Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.BMC Infect Dis. 2024 Feb 20;24(1):231. doi: 10.1186/s12879-024-09113-6. BMC Infect Dis. 2024. PMID: 38378528 Free PMC article.
-
Predicting Mortality for COVID-19 Patients Admitted to an Emergency Department Using Early Warning Scores in Poland.Healthcare (Basel). 2024 Mar 19;12(6):687. doi: 10.3390/healthcare12060687. Healthcare (Basel). 2024. PMID: 38540650 Free PMC article.
-
Mortality and COVID Infection: Predictors of Mortality 10 Months after Discharge.Diseases. 2024 Jun 5;12(6):123. doi: 10.3390/diseases12060123. Diseases. 2024. PMID: 38920555 Free PMC article.
References
-
- World health organization WHO coronavirus (COVID-19) dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data . Geneva, Switzerland: WHO; 2021. pp. 1–5.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical